Commercially available Human Probiotic microorganisms

Probiotics are microorganisms that are believed to provide health benefits when consumed.The term probiotic is currently used to name ingested microorganisms associated with benefits for humans and animals. A significant expansion of the potential market for probiotics has led to higher requirements for scientific substantiation of putative benefits conferred by the microorganisms.There are numerous claimed benefits of using commercial probiotics, such as reduction of gastrointestinal discomfort or strengthening of the immune system, such claims are not backed by scientific evidence.Yet one systematic review of 15 human randomized controlled trials from July 2016 found that certain commercially available strains of probiotic bacteria from the Bifidobacterium and Lactobacillus genera, when taken by mouth in daily doses of 109–1010 colony forming units (CFU) for 1–2 months, possess treatment efficacy (i.e., improved behavioral outcomes) in certain psychological disorders, e.g. anxiety, depression, autism spectrum disorder, and obsessive-compulsive disorder – and improved certain aspects of memory.

  • Bifidobacterium animalis spp. Lactis, BB-12®
  • Bifidobacterium breve Strain Yakult
  • Bifidobacterium longum BB536
  • Bifidobacterium longum Strain BL46 and BL2C
  • Lactobacillus rhamnosus GR-1®
  • Lactobacillus rhamnosus hn001
  • Bifidobacterium lactis HN019
  • Lactobacillus acidophilus NCFM®

Related Conference of Commercially available Human Probiotic microorganisms

May 30-31, 2024

23rd International Congress on Nutrition and Health

Amsterdam, Netherlands
June 27-29, 2024

5th World Summit on Food and Nutrition

London, UK
October 21-22, 2024

28th World Congress on Nutrition and Food Sciences

Paris, France

Commercially available Human Probiotic microorganisms Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in